Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab neutralizes conserved epitopes on subtypes A and B on RSV. Suptavumab can be used to study RSV infections and the respiratory system.
CAS Number:
[1629615-23-1]
Target:
RSV
* VAT and and shipping costs not included. Errors and price changes excepted